ID   M3K6_HUMAN              Reviewed;        1288 AA.
AC   O95382; A2ACE8; A2VDG4; A2VDG5; Q59HF4; Q5SSD4; Q75PK3; Q96B75;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   03-NOV-2009, sequence version 3.
DT   12-APR-2017, entry version 158.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 6;
DE            EC=2.7.11.25;
DE   AltName: Full=Apoptosis signal-regulating kinase 2;
GN   Name=MAP3K6; Synonyms=ASK2, MAPKKK6, MEKK6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ENZYME REGULATION,
RP   INTERACTION WITH MAP3K5, AND VARIANT ILE-455.
RX   PubMed=17210579; DOI=10.1074/jbc.M607177200;
RA   Takeda K., Shimozono R., Noguchi T., Umeda T., Morimoto Y., Naguro I.,
RA   Tobiume K., Saitoh M., Matsuzawa A., Ichijo H.;
RT   "Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-
RT   activated protein kinase kinase kinase in a heteromeric complex with
RT   ASK1.";
RL   J. Biol. Chem. 282:7522-7531(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 435-1288 (ISOFORMS 1/3), AND VARIANTS
RP   ILE-455 AND ASN-969.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 89-1288 (ISOFORM 3), AND
RP   VARIANT LYS-622.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 197-1288, FUNCTION, TISSUE SPECIFICITY,
RP   AND INTERACTION WITH MAP3K5.
RX   PubMed=9875215; DOI=10.1006/bbrc.1998.9749;
RA   Wang X.S., Diener K., Tan T.-H., Yao Z.;
RT   "MAPKKK6, a novel mitogen-activated protein kinase kinase kinase, that
RT   associates with MAPKKK5.";
RL   Biochem. Biophys. Res. Commun. 253:33-37(1998).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-984 AND SER-1129, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-984, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-984; SER-1129 AND
RP   SER-1149, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-964; SER-984 AND
RP   SER-1129, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-869.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] TRP-544; LYS-622; GLY-668; LEU-673;
RP   LEU-925; ILE-968 AND THR-1061.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Component of a protein kinase signal transduction
CC       cascade. Activates the JNK, but not ERK or p38 kinase pathways.
CC       {ECO:0000269|PubMed:17210579, ECO:0000269|PubMed:9875215}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Thr-806.
CC       Catalytically active only when complexed with MAP3K5, with MAP3K5
CC       supporting the stability and the active configuration of MAP3K6
CC       and MAP3K6 activating MAP3K5 by direct phosphorylation.
CC       {ECO:0000269|PubMed:17210579}.
CC   -!- SUBUNIT: Binds both upstream activators and downstream substrates
CC       in multimolecular complexes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O95382-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95382-2; Sequence=VSP_026201, VSP_026203, VSP_026204;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=O95382-3; Sequence=VSP_026202;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD05304.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB167411; BAD12485.1; -; mRNA.
DR   EMBL; FO393419; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC015914; AAH15914.1; -; mRNA.
DR   EMBL; BC129950; AAI29951.1; -; mRNA.
DR   EMBL; BC129951; AAI29952.1; -; mRNA.
DR   EMBL; AB208805; BAD92042.1; -; mRNA.
DR   EMBL; AF100318; AAD05304.1; ALT_INIT; mRNA.
DR   CCDS; CCDS299.1; -. [O95382-1]
DR   CCDS; CCDS72738.1; -. [O95382-3]
DR   RefSeq; NP_001284538.1; NM_001297609.1. [O95382-3]
DR   RefSeq; NP_004663.3; NM_004672.4. [O95382-1]
DR   UniGene; Hs.194694; -.
DR   ProteinModelPortal; O95382; -.
DR   SMR; O95382; -.
DR   BioGrid; 114524; 20.
DR   IntAct; O95382; 8.
DR   MINT; MINT-7997495; -.
DR   STRING; 9606.ENSP00000350195; -.
DR   BindingDB; O95382; -.
DR   ChEMBL; CHEMBL1163123; -.
DR   GuidetoPHARMACOLOGY; 2081; -.
DR   iPTMnet; O95382; -.
DR   PhosphoSitePlus; O95382; -.
DR   BioMuta; MAP3K6; -.
DR   EPD; O95382; -.
DR   MaxQB; O95382; -.
DR   PaxDb; O95382; -.
DR   PeptideAtlas; O95382; -.
DR   PRIDE; O95382; -.
DR   Ensembl; ENST00000357582; ENSP00000350195; ENSG00000142733. [O95382-1]
DR   Ensembl; ENST00000374040; ENSP00000363152; ENSG00000142733. [O95382-3]
DR   Ensembl; ENST00000493901; ENSP00000419591; ENSG00000142733. [O95382-1]
DR   GeneID; 9064; -.
DR   KEGG; hsa:9064; -.
DR   UCSC; uc001bny.2; human. [O95382-1]
DR   CTD; 9064; -.
DR   DisGeNET; 9064; -.
DR   GeneCards; MAP3K6; -.
DR   H-InvDB; HIX0000314; -.
DR   HGNC; HGNC:6858; MAP3K6.
DR   HPA; HPA051192; -.
DR   MalaCards; MAP3K6; -.
DR   MIM; 604468; gene.
DR   neXtProt; NX_O95382; -.
DR   OpenTargets; ENSG00000142733; -.
DR   PharmGKB; PA30602; -.
DR   eggNOG; KOG4279; Eukaryota.
DR   eggNOG; ENOG410XQGS; LUCA.
DR   GeneTree; ENSGT00800000124036; -.
DR   HOVERGEN; HBG006305; -.
DR   InParanoid; O95382; -.
DR   KO; K04425; -.
DR   OMA; KMQYYWD; -.
DR   OrthoDB; EOG091G00SJ; -.
DR   PhylomeDB; O95382; -.
DR   TreeFam; TF105115; -.
DR   BRENDA; 2.7.11.25; 2681.
DR   SignaLink; O95382; -.
DR   ChiTaRS; MAP3K6; human.
DR   GenomeRNAi; 9064; -.
DR   PRO; PR:O95382; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000142733; -.
DR   CleanEx; HS_MAP3K6; -.
DR   ExpressionAtlas; O95382; baseline and differential.
DR   Genevisible; O95382; HS.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 1.25.40.10; -; 1.
DR   InterPro; IPR025136; DUF4071.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR013761; SAM/pointed.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR011990; TPR-like_helical_dom.
DR   Pfam; PF13281; DUF4071; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Coiled coil; Complete proteome;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1   1288       Mitogen-activated protein kinase kinase
FT                                kinase 6.
FT                                /FTId=PRO_0000086251.
FT   DOMAIN      648    906       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     654    662       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COILED     1004   1029       {ECO:0000255}.
FT   COILED     1166   1205       {ECO:0000255}.
FT   ACT_SITE    771    771       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     677    677       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     806    806       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9WTR2}.
FT   MOD_RES     964    964       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     984    984       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1129   1129       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1149   1149       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   VAR_SEQ       1    277       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026201.
FT   VAR_SEQ     161    168       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_026202.
FT   VAR_SEQ    1065   1074       RLRAQGLGPA -> WMNGEDKGSF (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026203.
FT   VAR_SEQ    1075   1288       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026204.
FT   VARIANT     455    455       T -> I (in dbSNP:rs1138294).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17210579}.
FT                                /FTId=VAR_032832.
FT   VARIANT     499    499       R -> C (in dbSNP:rs11247641).
FT                                /FTId=VAR_046050.
FT   VARIANT     544    544       R -> W (in dbSNP:rs55671988).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_046051.
FT   VARIANT     622    622       N -> K (in dbSNP:rs35659744).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_032833.
FT   VARIANT     668    668       R -> G (in dbSNP:rs55869163).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_046052.
FT   VARIANT     673    673       R -> L (in dbSNP:rs56359841).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_046053.
FT   VARIANT     869    869       P -> T (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035629.
FT   VARIANT     925    925       S -> L (in a breast pleomorphic lobular
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_046054.
FT   VARIANT     968    968       T -> I (in an ovarian endometrioid cancer
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_046055.
FT   VARIANT     969    969       S -> N (in dbSNP:rs17856498).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_032834.
FT   VARIANT    1061   1061       A -> T (in dbSNP:rs55990440).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_046056.
FT   VARIANT    1233   1233       G -> A (in dbSNP:rs17162549).
FT                                /FTId=VAR_046057.
FT   CONFLICT    435    440       MQYYWD -> ALWVPV (in Ref. 3; AAI29952).
FT                                {ECO:0000305}.
FT   CONFLICT    435    440       MQYYWD -> HTWVPV (in Ref. 3; AAI29951).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1288 AA;  142596 MW;  013AF3729698080F CRC64;
     MAGPCPRSGA ERAGSCWQDP LAVALSRGRQ LAAPPGRGCA RSRPLSVVYV LTREPQPGLE
     PREGTEAEPL PLRCLREACA QVPRPRPPPQ LRSLPFGTLE LGDTAALDAF YNADVVVLEV
     SSSLVQPSLF YHLGVRESFS MTNNVLLCSQ ADLPDLQALR EDVFQKNSDC VGSYTLIPYV
     VTATGRVLCG DAGLLRGLAD GLVQAGVGTE ALLTPLVGRL ARLLEATPTD SCGYFRETIR
     RDIRQARERF SGPQLRQELA RLQRRLDSVE LLSPDIIMNL LLSYRDVQDY SAIIELVETL
     QALPTCDVAE QHNVCFHYTF ALNRRNRPGD RAKALSVLLP LVQLEGSVAP DLYCMCGRIY
     KDMFFSSGFQ DAGHREQAYH WYRKAFDVEP SLHSGINAAV LLIAAGQHFE DSKELRLIGM
     KLGCLLARKG CVEKMQYYWD VGFYLGAQIL ANDPTQVVLA AEQLYKLNAP IWYLVSVMET
     FLLYQHFRPT PEPPGGPPRR AHFWLHFLLQ SCQPFKTACA QGDQCLVLVL EMNKVLLPAK
     LEVRGTDPVS TVTLSLLEPE TQDIPSSWTF PVASICGVSA SKRDERCCFL YALPPAQDVQ
     LCFPSVGHCQ WFCGLIQAWV TNPDSTAPAE EAEGAGEMLE FDYEYTETGE RLVLGKGTYG
     VVYAGRDRHT RVRIAIKEIP ERDSRFSQPL HEEIALHRRL RHKNIVRYLG SASQGGYLKI
     FMEEVPGGSL SSLLRSVWGP LKDNESTISF YTRQILQGLG YLHDNHIVHR DIKGDNVLIN
     TFSGLLKISD FGTSKRLAGI TPCTETFTGT LQYMAPEIID QGPRGYGKAA DIWSLGCTVI
     EMATGRPPFH ELGSPQAAMF QVGMYKVHPP MPSSLSAEAQ AFLLRTFEPD PRLRASAQTL
     LGDPFLQPGK RSRSPSSPRH APRPSDAPSA SPTPSANSTT QSQTFPCPQA PSQHPPSPPK
     RCLSYGGTSQ LRVPEEPAAE EPASPEESSG LSLLHQESKR RAMLAAVLEQ ELPALAENLH
     QEQKQEQGAR LGRNHVEELL RCLGAHIHTP NRRQLAQELR ALQGRLRAQG LGPALLHRPL
     FAFPDAVKQI LRKRQIRPHW MFVLDSLLSR AVRAALGVLG PEVEKEAVSP RSEELSNEGD
     SQQSPGQQSP LPVEPEQGPA PLMVQLSLLR AETDRLREIL AGKEREYQAL VQRALQRLNE
     EARTYVLAPE PPTALSTDQG LVQWLQELNV DSGTIQMLLN HSFTLHTLLT YATRDDLIYT
     RIRGGMVCRI WRAILAQRAG STPVTSGP
//
